Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.

Publication | Closed Access

DOI

Citations

References

1996

Year

J.E. Leysen, W Gommeren, Lieve Heylen, Walter Luyten, Inez Van de Weyer, Piet Vanhoenacker, Guy Haegeman, Alain Schotte, Paul Van Gompel, Ria Wouters,

Molecular Pharmacology